The Federal Trade Commission says Abbott Laboratories (ABT) can proceed with its proposed $25 billion acquisition of St. Jude Medical (STJ) . As a result of the green light, Abbott will sell two medical device units to Tokyo-based Terumo for $1.2 billion. The merger of Abbot and St. Jude was cleared by European antitrust regulators back in November, provided that U.S. regulators were on board with the transaction.

More from Video

Legendary Technician Gives Her View of the Current Market

Legendary Technician Gives Her View of the Current Market

Jim Cramer: Be Careful in the Cannabis Stocks

Jim Cramer: Be Careful in the Cannabis Stocks

We Asked Our Pros About the Longevity of the Bull Market

We Asked Our Pros About the Longevity of the Bull Market

Want to Buy Stocks for a 10% or Greater Discount? Try Closed-End Funds

Want to Buy Stocks for a 10% or Greater Discount? Try Closed-End Funds

Want to Buy $1 Worth of Stock for 90 Cents or Less?

Want to Buy $1 Worth of Stock for 90 Cents or Less?